Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anti-tuberculosis Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-tuberculosis Therapeuticsmarket, defines the market attractiveness level of Anti-tuberculosis Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-tuberculosis Therapeutics industry, describes the types of Anti-tuberculosis Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-tuberculosis Therapeutics market and the development prospects and opportunities of Anti-tuberculosis Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-tuberculosis Therapeutics market in Chapter 13.
By Player:
Healthy Life Pharma Private Limited
Johnson and Johnson
Pfizer Inc
Novartis AG
Otsuka Pharmaceutical Co Ltd
Mylan
Macleods Pharmaceuticals Ltd
Lupin Limited
Sun Pharmaceutical Industries
By Type:
Isoniazid
Rifampin
Ethambutol
Pyrazinamide
Fluoroquinolones
Bedaquiline
Amynoglycosides
Thioamides
Cyclic Peptides
Other Drug Classes
By End-User:
Hospitals and Clinics
Government Agencies
Non Profit Organizations
Other End Users
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-tuberculosis Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-tuberculosis Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-tuberculosis Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-tuberculosis Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-tuberculosis Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Anti-tuberculosis Therapeutics Consumption (2017-2022)
-
7.2 United States Anti-tuberculosis Therapeutics Consumption (2017-2022)
-
7.3 Europe Anti-tuberculosis Therapeutics Consumption (2017-2022)
-
7.4 China Anti-tuberculosis Therapeutics Consumption (2017-2022)
-
7.5 Japan Anti-tuberculosis Therapeutics Consumption (2017-2022)
-
7.6 India Anti-tuberculosis Therapeutics Consumption (2017-2022)
-
7.7 South Korea Anti-tuberculosis Therapeutics Consumption (2017-2022)
8 Region and Country-wise Anti-tuberculosis Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Anti-tuberculosis Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Anti-tuberculosis Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Anti-tuberculosis Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Anti-tuberculosis Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Anti-tuberculosis Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Anti-tuberculosis Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-tuberculosis Therapeutics Consumption Forecast (2022-2028)
9 Global Anti-tuberculosis Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-tuberculosis Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Isoniazid Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Rifampin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Ethambutol Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Pyrazinamide Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Fluoroquinolones Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Bedaquiline Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Amynoglycosides Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Thioamides Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Cyclic Peptides Consumption and Growth Rate (2017-2022)
-
9.1.10 Global Other Drug Classes Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-tuberculosis Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Government Agencies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Non Profit Organizations Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other End Users Consumption and Growth Rate (2017-2022)
10 Global Anti-tuberculosis Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-tuberculosis Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Isoniazid Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Rifampin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Ethambutol Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Pyrazinamide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Fluoroquinolones Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Bedaquiline Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Amynoglycosides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Thioamides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.9 Global Cyclic Peptides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.10 Global Other Drug Classes Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-tuberculosis Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Government Agencies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Non Profit Organizations Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other End Users Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-tuberculosis Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-tuberculosis Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-tuberculosis Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-tuberculosis Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-tuberculosis Therapeutics Market Competitive Analysis
-
14.1 Healthy Life Pharma Private Limited
-
14.1.1 Healthy Life Pharma Private Limited Company Details
-
14.1.2 Healthy Life Pharma Private Limited Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Healthy Life Pharma Private Limited Anti-tuberculosis Therapeutics Product and Service
-
14.2 Johnson and Johnson
-
14.2.1 Johnson and Johnson Company Details
-
14.2.2 Johnson and Johnson Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Johnson and Johnson Anti-tuberculosis Therapeutics Product and Service
-
14.3 Pfizer Inc
-
14.3.1 Pfizer Inc Company Details
-
14.3.2 Pfizer Inc Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Inc Anti-tuberculosis Therapeutics Product and Service
-
14.4 Novartis AG
-
14.4.1 Novartis AG Company Details
-
14.4.2 Novartis AG Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis AG Anti-tuberculosis Therapeutics Product and Service
-
14.5 Otsuka Pharmaceutical Co Ltd
-
14.5.1 Otsuka Pharmaceutical Co Ltd Company Details
-
14.5.2 Otsuka Pharmaceutical Co Ltd Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Otsuka Pharmaceutical Co Ltd Anti-tuberculosis Therapeutics Product and Service
-
14.6 Mylan
-
14.6.1 Mylan Company Details
-
14.6.2 Mylan Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Mylan Anti-tuberculosis Therapeutics Product and Service
-
14.7 Macleods Pharmaceuticals Ltd
-
14.7.1 Macleods Pharmaceuticals Ltd Company Details
-
14.7.2 Macleods Pharmaceuticals Ltd Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Macleods Pharmaceuticals Ltd Anti-tuberculosis Therapeutics Product and Service
-
14.8 Lupin Limited
-
14.8.1 Lupin Limited Company Details
-
14.8.2 Lupin Limited Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Lupin Limited Anti-tuberculosis Therapeutics Product and Service
-
14.9 Sun Pharmaceutical Industries
-
14.9.1 Sun Pharmaceutical Industries Company Details
-
14.9.2 Sun Pharmaceutical Industries Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Sun Pharmaceutical Industries Anti-tuberculosis Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-tuberculosis Therapeutics
-
Figure Anti-tuberculosis Therapeutics Picture
-
Table Global Anti-tuberculosis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-tuberculosis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-tuberculosis Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-tuberculosis Therapeutics Consumption by Country (2017-2022)
-
Figure United States Anti-tuberculosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-tuberculosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Anti-tuberculosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-tuberculosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Anti-tuberculosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-tuberculosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-tuberculosis Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-tuberculosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-tuberculosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-tuberculosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-tuberculosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-tuberculosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-tuberculosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Isoniazid Consumption and Growth Rate (2017-2022)
-
Figure Global Rifampin Consumption and Growth Rate (2017-2022)
-
Figure Global Ethambutol Consumption and Growth Rate (2017-2022)
-
Figure Global Pyrazinamide Consumption and Growth Rate (2017-2022)
-
Figure Global Fluoroquinolones Consumption and Growth Rate (2017-2022)
-
Figure Global Bedaquiline Consumption and Growth Rate (2017-2022)
-
Figure Global Amynoglycosides Consumption and Growth Rate (2017-2022)
-
Figure Global Thioamides Consumption and Growth Rate (2017-2022)
-
Figure Global Cyclic Peptides Consumption and Growth Rate (2017-2022)
-
Figure Global Other Drug Classes Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Government Agencies Consumption and Growth Rate (2017-2022)
-
Figure Global Non Profit Organizations Consumption and Growth Rate (2017-2022)
-
Figure Global Other End Users Consumption and Growth Rate (2017-2022)
-
Figure Global Isoniazid Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rifampin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ethambutol Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pyrazinamide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fluoroquinolones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bedaquiline Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Amynoglycosides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Thioamides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cyclic Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Drug Classes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Government Agencies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non Profit Organizations Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other End Users Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-tuberculosis Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-tuberculosis Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Healthy Life Pharma Private Limited (Foundation Year, Company Profile and etc.)
-
Table Healthy Life Pharma Private Limited Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Healthy Life Pharma Private Limited Anti-tuberculosis Therapeutics Product and Service
-
Table Johnson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson and Johnson Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Anti-tuberculosis Therapeutics Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Anti-tuberculosis Therapeutics Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Anti-tuberculosis Therapeutics Product and Service
-
Table Otsuka Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Otsuka Pharmaceutical Co Ltd Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Pharmaceutical Co Ltd Anti-tuberculosis Therapeutics Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Anti-tuberculosis Therapeutics Product and Service
-
Table Macleods Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)
-
Table Macleods Pharmaceuticals Ltd Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Macleods Pharmaceuticals Ltd Anti-tuberculosis Therapeutics Product and Service
-
Table Lupin Limited (Foundation Year, Company Profile and etc.)
-
Table Lupin Limited Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Limited Anti-tuberculosis Therapeutics Product and Service
-
Table Sun Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceutical Industries Anti-tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Industries Anti-tuberculosis Therapeutics Product and Service
-
